Copyright
©The Author(s) 2017.
World J Cardiol. Aug 26, 2017; 9(8): 673-684
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
Figure 6 Activation of the fetal hypertrophic gene program in dominant negative cyclic AMP response-element binding protein and double transgenic mice.
A: Myosin heavy chain α (MYHCα) expression was unchanged by either sex or genotype; B: Myosin heavy chain β (MYHCβ); C: Atrial natriuretic factor (ANF); D: Brain natriuretic peptide (BNP) were all significantly upregulated in both male and female dnCREB and DTG mice; E: Sarcoplasmic reticulum Ca2+ ATPase (SERCA) expression was significantly downregulated in both sexes with disease. Expression of fetal hypertrophic genes was assessed by qRT-PCR, relative to the housekeeping gene 18S. Data are expressed as mean ± SEM and assessed by 2-way ANOVA. aP < 0.05 vs Control; n = 4-7 mice per group. a: Significant effect of genotype. dnCREB: Do-minant negative cyclic AMP response-element binding protein; DTG: Double transgenic.
- Citation: Bruns DR, Ghincea AR, Ghincea CV, Azuma YT, Watson PA, Autieri MV, Walker LA. Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner. World J Cardiol 2017; 9(8): 673-684
- URL: https://www.wjgnet.com/1949-8462/full/v9/i8/673.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i8.673